Documents
Application Sponsors
NDA 022359 | BAXTER HLTHCARE CORP | |
Marketing Status
None (Tentative Approval) | 001 |
Application Products
001 | INJECTABLE; INJECTION | 250MG/250ML | 0 | ARGATROBAN | ARGATROBAN |
FDA Submissions
TYPE 5; Type 5 - New Formulation or New Manufacturer | ORIG | 1 | TA | 2010-07-28 | STANDARD |
Submissions Property Types
CDER Filings
BAXTER HLTHCARE CORP
cder:Array
(
[0] => Array
(
[ApplNo] => 22359
[companyName] => BAXTER HLTHCARE CORP
[docInserts] => ["",""]
[products] => [{"drugName":"ARGATROBAN","activeIngredients":"ARGATROBAN","strength":"250MG\/250ML","dosageForm":"INJECTABLE; INJECTION","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"ARGATROBAN","submission":"ARGATROBAN","actionType":"250MG\/250ML","submissionClassification":"INJECTABLE; INJECTION","reviewPriority":"None (Tentative Approval)","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)